id	sid	eid	entity	type
cana-5164	1	1	1074	CARDINAL
cana-5164	1	2	32	CARDINAL
cana-5164	2	1	2025	CARDINAL
cana-5164	3	1	kaur2	ORG
cana-5164	3	2	1school	CARDINAL
cana-5164	3	3	ct university	ORG
cana-5164	3	4	khurd-142024	DATE
cana-5164	3	5	india	GPE
cana-5164	3	6	2	CARDINAL
cana-5164	3	7	hayat nagar	PERSON
cana-5164	3	8	punjab-143521	TIME
cana-5164	3	9	india	GPE
cana-5164	3	10	3	CARDINAL
cana-5164	3	11	punjab-146101	GPE
cana-5164	3	12	india	GPE
cana-5164	4	1	viceprincipal@ctuniversity.in	PERSON
cana-5164	4	2	12	CARDINAL
cana-5164	4	3	25-01-2025	CARDINAL
cana-5164	4	4	05-02-2025	CARDINAL
cana-5164	17	1	at least one	CARDINAL
cana-5164	17	2	100	CARDINAL
cana-5164	20	1	1074	CARDINAL
cana-5164	20	2	32	CARDINAL
cana-5164	21	1	2025	CARDINAL
cana-5164	21	2	1410	DATE
cana-5164	22	1	beena	ORG
cana-5164	28	1	•	CARDINAL
cana-5164	29	1	•	CARDINAL
cana-5164	30	1	•	CARDINAL
cana-5164	31	1	•	CARDINAL
cana-5164	32	1	•	CARDINAL
cana-5164	33	1	•	CARDINAL
cana-5164	34	1	•	CARDINAL
cana-5164	39	1	1074	CARDINAL
cana-5164	39	2	32	CARDINAL
cana-5164	40	1	2025	CARDINAL
cana-5164	40	2	1411	CARDINAL
cana-5164	46	1	three	CARDINAL
cana-5164	59	1	diameterin	NORP
cana-5164	61	1	30–50	CARDINAL
cana-5164	63	1	three	CARDINAL
cana-5164	64	1	one	CARDINAL
cana-5164	67	1	1074	CARDINAL
cana-5164	67	2	32	CARDINAL
cana-5164	68	1	2025	CARDINAL
cana-5164	68	2	1412	CARDINAL
cana-5164	70	1	1	CARDINAL
cana-5164	71	1	dds drug loading technology	ORG
cana-5164	72	1	around 60%	PERCENT
cana-5164	73	1	2	CARDINAL
cana-5164	74	1	1	CARDINAL
cana-5164	74	2	3	CARDINAL
cana-5164	76	1	4	CARDINAL
cana-5164	78	1	5	CARDINAL
cana-5164	78	2	6	CARDINAL
cana-5164	80	1	9	CARDINAL
cana-5164	82	1	1074	CARDINAL
cana-5164	82	2	32	CARDINAL
cana-5164	83	1	2025	CARDINAL
cana-5164	83	2	1413	CARDINAL
cana-5164	84	1	11	CARDINAL
cana-5164	86	1	mateo et al	PERSON
cana-5164	87	1	12	CARDINAL
cana-5164	90	1	13	CARDINAL
cana-5164	91	1	dagli et al	PERSON
cana-5164	92	1	14	CARDINAL
cana-5164	92	2	edc-nhsactivation	ORG
cana-5164	93	1	4	CARDINAL
cana-5164	93	2	edc/nhs activation.the	ORG
cana-5164	93	3	pan/pu andpan/pu/p3ana	PRODUCT
cana-5164	93	4	0.075	CARDINAL
cana-5164	93	5	0.150	CARDINAL
cana-5164	93	6	103 ± 11	MONEY
cana-5164	93	7	144 ± 24,111 ±	MONEY
cana-5164	93	8	119 ± 22	QUANTITY
cana-5164	94	1	87%	PERCENT
cana-5164	96	1	15	CARDINAL
cana-5164	98	1	al	PERSON
cana-5164	99	1	16	CARDINAL
cana-5164	101	1	17	CARDINAL
cana-5164	102	1	dds	ORG
cana-5164	103	1	1074	CARDINAL
cana-5164	103	2	32	CARDINAL
cana-5164	104	1	2025	CARDINAL
cana-5164	104	2	1414	CARDINAL
cana-5164	104	3	2	CARDINAL
cana-5164	104	4	dds oral administration oral administration	ORG
cana-5164	104	5	more than half	CARDINAL
cana-5164	104	6	fda	ORG
cana-5164	104	7	18	CARDINAL
cana-5164	106	1	19	CARDINAL
cana-5164	108	1	liang et al.[20,21	PERSON
cana-5164	109	1	zwitterionic dilauroyl phos-phatidylcholine	ORG
cana-5164	111	1	22	CARDINAL
cana-5164	111	2	pva)/carboxymethyl	CARDINAL
cana-5164	113	1	23	CARDINAL
cana-5164	113	2	100	CARDINAL
cana-5164	114	1	1074	CARDINAL
cana-5164	114	2	32	CARDINAL
cana-5164	115	1	2025	CARDINAL
cana-5164	115	2	1415	DATE
cana-5164	115	3	24	CARDINAL
cana-5164	118	1	25	CARDINAL
cana-5164	119	1	26	CARDINAL
cana-5164	120	1	27	CARDINAL
cana-5164	121	1	neuberg et al	PERSON
cana-5164	122	1	28	CARDINAL
cana-5164	123	1	johnson et al	PERSON
cana-5164	124	1	29	CARDINAL
cana-5164	124	2	gelatin	ORG
cana-5164	128	1	first	ORDINAL
cana-5164	129	1	sec	ORG
cana-5164	130	1	elshazly et al	PERSON
cana-5164	131	1	30	CARDINAL
cana-5164	132	1	new zealand	GPE
cana-5164	134	1	nhlapo	TIME
cana-5164	135	1	31	CARDINAL
cana-5164	135	2	year	DATE
cana-5164	136	1	32	CARDINAL
cana-5164	137	1	1074	CARDINAL
cana-5164	137	2	32	CARDINAL
cana-5164	138	1	2025	CARDINAL
cana-5164	138	2	1416	CARDINAL
cana-5164	139	1	first	ORDINAL
cana-5164	139	2	33	CARDINAL
cana-5164	141	1	34].transdermal	CARDINAL
cana-5164	142	1	shekh et al	PERSON
cana-5164	143	1	35	CARDINAL
cana-5164	145	1	36	CARDINAL
cana-5164	145	2	37	DATE
cana-5164	145	3	38	CARDINAL
cana-5164	145	4	39	CARDINAL
cana-5164	146	1	zheng et al	PERSON
cana-5164	147	1	39	CARDINAL
cana-5164	148	1	5:1	CARDINAL
cana-5164	151	1	dds polymeric nanofibers	ORG
cana-5164	151	2	40	CARDINAL
cana-5164	152	1	3	CARDINAL
cana-5164	152	2	dds communications	ORG
cana-5164	152	3	1074	CARDINAL
cana-5164	152	4	32	CARDINAL
cana-5164	153	1	2025	CARDINAL
cana-5164	153	2	1417	CARDINAL
cana-5164	153	3	ecm	ORG
cana-5164	154	1	40	CARDINAL
cana-5164	154	2	ecm	ORG
cana-5164	155	1	ecm	ORG
cana-5164	156	1	niu et al	ORG
cana-5164	157	1	41	CARDINAL
cana-5164	159	1	42,43,44	CARDINAL
cana-5164	159	2	scaf	GPE
cana-5164	160	1	rezk et al	PERSON
cana-5164	161	1	45	CARDINAL
cana-5164	161	2	pcl	ORG
cana-5164	161	3	polyglycerol sebacate	PERSON
cana-5164	161	4	simvastatin	PRODUCT
cana-5164	161	5	ecm	ORG
cana-5164	163	1	pcl-pgs	ORG
cana-5164	163	2	pcl-pgs-ha	ORG
cana-5164	163	3	pcl-pgs-ha-simreached	PERSON
cana-5164	163	4	0.86 ± 0.34	MONEY
cana-5164	163	5	0.87 ± 0.35	MONEY
cana-5164	163	6	0.88 ±	MONEY
cana-5164	164	1	pcl	ORG
cana-5164	164	2	around 20%	PERCENT
cana-5164	164	3	24	CARDINAL
cana-5164	164	4	7 days	DATE
cana-5164	165	1	thegrowth	CARDINAL
cana-5164	166	1	day 2	DATE
cana-5164	166	2	day 6	DATE
cana-5164	166	3	pcl-pgs-ha-sim composite nanofibers	ORG
cana-5164	169	1	46	CARDINAL
cana-5164	169	2	2	CARDINAL
cana-5164	170	1	7.2	CARDINAL
cana-5164	170	2	4.8	CARDINAL
cana-5164	171	1	1.19 ± 0.34 µm	MONEY
cana-5164	172	1	37.6 ± 1.8%	PERCENT
cana-5164	172	2	the first 8 h	DATE
cana-5164	172	3	81.7 ± 1.8%	PERCENT
cana-5164	172	4	7thday	DATE
cana-5164	173	1	day 7	DATE
cana-5164	173	2	less than 1%	PERCENT
cana-5164	173	3	day 14	DATE
cana-5164	173	4	91.6 ± 1.8%	MONEY
cana-5164	177	1	1074	CARDINAL
cana-5164	177	2	32	CARDINAL
cana-5164	178	1	2025	CARDINAL
cana-5164	178	2	1418	CARDINAL
cana-5164	179	1	1.5–4.0 mm	QUANTITY
cana-5164	179	2	47	CARDINAL
cana-5164	180	1	47	CARDINAL
cana-5164	181	1	1	CARDINAL
cana-5164	181	2	2	CARDINAL
cana-5164	181	3	3	CARDINAL
cana-5164	181	4	4	CARDINAL
cana-5164	181	5	5	CARDINAL
cana-5164	181	6	6	CARDINAL
cana-5164	181	7	7	CARDINAL
cana-5164	181	8	8)	CARDINAL
cana-5164	182	1	years	DATE
cana-5164	184	1	48-54	CARDINAL
cana-5164	185	1	pcl	ORG
cana-5164	185	2	egf	ORG
cana-5164	187	1	jafari et al	PERSON
cana-5164	188	1	55	CARDINAL
cana-5164	188	2	pcl	ORG
cana-5164	189	1	± 197.77	CARDINAL
cana-5164	190	1	24	CARDINAL
cana-5164	190	2	144	CARDINAL
cana-5164	191	1	twelve	CARDINAL
cana-5164	191	2	200–250	CARDINAL
cana-5164	191	3	4%zno	DATE
cana-5164	191	4	15%	PERCENT
cana-5164	192	1	day 3	DATE
cana-5164	192	2	4.93	MONEY
cana-5164	192	3	46.58 ± 3.66%	MONEY
cana-5164	192	4	day 6	DATE
cana-5164	192	5	64.77 ± 3.35	MONEY
cana-5164	192	6	69.44 ± 3.65%	PERCENT
cana-5164	192	7	day 10	DATE
cana-5164	192	8	95.07 ±	CARDINAL
cana-5164	192	9	1074	CARDINAL
cana-5164	192	10	32	CARDINAL
cana-5164	193	1	2025	CARDINAL
cana-5164	193	2	1419	CARDINAL
cana-5164	193	3	1.51	CARDINAL
cana-5164	193	4	95.60 ± 2.99%	MONEY
cana-5164	193	5	day 13	DATE
cana-5164	193	6	the first three days	DATE
cana-5164	195	1	56	CARDINAL
cana-5164	196	1	bloodrelease	ORG
cana-5164	197	1	57	CARDINAL
cana-5164	198	1	58	CARDINAL
cana-5164	200	1	shi et al	PERSON
cana-5164	201	1	59	CARDINAL
cana-5164	201	2	pcl/pnipaam	ORG
cana-5164	203	1	up to 100%	PERCENT
cana-5164	204	1	shi et al	PERSON
cana-5164	205	1	60	CARDINAL
cana-5164	205	2	pcl	ORG
cana-5164	205	3	5/5/1	CARDINAL
cana-5164	205	4	5/5/2	CARDINAL
cana-5164	205	5	pcl	ORG
cana-5164	205	6	pcl	ORG
cana-5164	206	1	9a	CARDINAL
cana-5164	207	1	nk	ORG
cana-5164	207	2	37 °	QUANTITY
cana-5164	207	3	nk formore	PERSON
cana-5164	207	4	pcl	ORG
cana-5164	207	5	37 °	QUANTITY
cana-5164	207	6	120°	QUANTITY
cana-5164	207	7	25°	QUANTITY
cana-5164	207	8	24°	QUANTITY
cana-5164	207	9	25 °	QUANTITY
cana-5164	209	1	nk	ORG
cana-5164	209	2	to100%	PERCENT
cana-5164	210	1	about 32 °	CARDINAL
cana-5164	210	2	nk	ORG
cana-5164	210	3	32 °	QUANTITY
cana-5164	211	1	1074	CARDINAL
cana-5164	211	2	32	CARDINAL
cana-5164	212	1	2025	CARDINAL
cana-5164	212	2	1420	CARDINAL
cana-5164	212	3	61	CARDINAL
cana-5164	214	1	firstly	ORDINAL
cana-5164	215	1	62	CARDINAL
cana-5164	216	1	secondly	ORDINAL
cana-5164	216	2	cu	ORG
cana-5164	217	1	63,64].finally	CARDINAL
cana-5164	218	1	centella asiatica	ORG
cana-5164	219	1	e. coli	PERSON
cana-5164	220	1	65	CARDINAL
cana-5164	222	1	66	CARDINAL
cana-5164	222	2	pcl	ORG
cana-5164	222	3	0:100	CARDINAL
cana-5164	222	4	5:95	DATE
cana-5164	222	5	and15:85	NORP
cana-5164	223	1	pcl/cip,5peg/95pcl/cip	ORG
cana-5164	223	2	10peg/90pcl	CARDINAL
cana-5164	223	3	15peg/85pcl	CARDINAL
cana-5164	223	4	123.41 ± 27.92	MONEY
cana-5164	223	5	41.99	CARDINAL
cana-5164	223	6	136.10 ± 23.82	MONEY
cana-5164	223	7	± 17.24 μm	QUANTITY
cana-5164	224	1	four	CARDINAL
cana-5164	224	2	about 16	CARDINAL
cana-5164	224	3	48	DATE
cana-5164	224	4	36	DATE
cana-5164	224	5	the first 12 h	DATE
cana-5164	225	1	168	CARDINAL
cana-5164	225	2	four	CARDINAL
cana-5164	225	3	60, 72	DATE
cana-5164	225	4	75	DATE
cana-5164	225	5	90%	PERCENT
cana-5164	226	1	four	CARDINAL
cana-5164	226	2	2.49 ± 0.14	MONEY
cana-5164	226	3	2.18 ±	MONEY
cana-5164	226	4	2.64 ± 0.21	QUANTITY
cana-5164	226	5	2.91 ± 0.17 mm	MONEY
cana-5164	226	6	s. aureus	PERSON
cana-5164	226	7	1.92 ± 0.22	MONEY
cana-5164	226	8	1.86 ± 0.13	QUANTITY
cana-5164	226	9	2.32 ±	CARDINAL
cana-5164	226	10	2.65 ± 0.15 mm	MONEY
cana-5164	227	1	10	CARDINAL
cana-5164	228	1	67	CARDINAL
cana-5164	231	1	67	CARDINAL
cana-5164	231	2	1074	CARDINAL
cana-5164	231	3	32	CARDINAL
cana-5164	232	1	2025	CARDINAL
cana-5164	232	2	1421	CARDINAL
cana-5164	233	1	sharma et al	PERSON
cana-5164	234	1	68	CARDINAL
cana-5164	236	1	70	CARDINAL
cana-5164	237	1	souza et al	PERSON
cana-5164	238	1	71	CARDINAL
cana-5164	238	2	10	CARDINAL
cana-5164	238	3	15	DATE
cana-5164	238	4	20	CARDINAL
cana-5164	240	1	about 200	CARDINAL
cana-5164	241	1	half	CARDINAL
cana-5164	241	2	1645	CARDINAL
cana-5164	241	3	10	CARDINAL
cana-5164	241	4	411	CARDINAL
cana-5164	241	5	15wt.%	CARDINAL
cana-5164	241	6	291	CARDINAL
cana-5164	241	7	20	CARDINAL
cana-5164	241	8	575s	CARDINAL
cana-5164	241	9	329s	PRODUCT
cana-5164	241	10	solu	GPE
cana-5164	248	1	first	ORDINAL
cana-5164	250	1	dds	ORG
cana-5164	250	2	guidancefor	PERSON
cana-5164	250	3	1074	CARDINAL
cana-5164	250	4	32	CARDINAL
cana-5164	251	1	2025	CARDINAL
cana-5164	251	2	1422	CARDINAL
cana-5164	251	3	dds	ORG
cana-5164	252	1	first	ORDINAL
cana-5164	253	1	148	CARDINAL
cana-5164	253	2	naproxen	ORG
cana-5164	255	1	second	ORDINAL
cana-5164	259	1	1	CARDINAL
cana-5164	259	2	garg t	PERSON
cana-5164	260	1	artif	PERSON
cana-5164	260	2	biotechnol	DATE
cana-5164	261	1	2016	CARDINAL
cana-5164	261	2	44(1):135	CARDINAL
cana-5164	262	1	2	CARDINAL
cana-5164	262	2	liu t	PERSON
cana-5164	262	3	chen m	PERSON
cana-5164	262	4	fu j	PERSON
cana-5164	262	5	sun y	PERSON
cana-5164	262	6	quan g	PERSON
cana-5164	264	1	acta pharmaceutica sin b. 2021;11:2326–43	PERSON
cana-5164	265	1	3	CARDINAL
cana-5164	265	2	pispas s. drug	PERSON
cana-5164	268	1	4	CARDINAL
cana-5164	268	2	sokolov av	PERSON
cana-5164	268	3	limareva lv	PERSON
cana-5164	268	4	iliasov	ORG
cana-5164	270	1	russian	NORP
cana-5164	272	1	5	CARDINAL
cana-5164	272	2	mendes ac	PERSON
cana-5164	275	1	2019	DATE
cana-5164	275	2	206:38–47	DATE
cana-5164	276	1	6	CARDINAL
cana-5164	276	2	edwards k	PERSON
cana-5164	276	3	neumann j. investigation	PERSON
cana-5164	276	4	poly(ethylene	ORG
cana-5164	279	1	li w	PERSON
cana-5164	279	2	amirsaadat s	ORG
cana-5164	279	3	alijani s.	PERSON
cana-5164	280	1	j biomed mater res	PERSON
cana-5164	280	2	a. 2021;110:316–30	PERSON
cana-5164	281	1	10.1002	CARDINAL
cana-5164	282	1	8	CARDINAL
cana-5164	282	2	dudak fc	PERSON
cana-5164	284	1	2021;264:117990	CARDINAL
cana-5164	285	1	9	CARDINAL
cana-5164	285	2	jiang x	PERSON
cana-5164	287	1	2010;144:203–12	PERSON
cana-5164	288	1	1074	CARDINAL
cana-5164	288	2	32	CARDINAL
cana-5164	289	1	2025	CARDINAL
cana-5164	289	2	1423	CARDINAL
cana-5164	290	1	10	CARDINAL
cana-5164	290	2	castro s	PERSON
cana-5164	290	3	lagaron jm	PERSON
cana-5164	290	4	ketoprofen anti	ORG
cana-5164	291	1	sci eng	PERSON
cana-5164	293	1	11	CARDINAL
cana-5164	293	2	wang s	PERSON
cana-5164	293	3	wang m	PERSON
cana-5164	293	4	hu x	PERSON
cana-5164	293	5	li g.	PERSON
cana-5164	294	1	sci eng	PERSON
cana-5164	294	2	2015;38:112–6	CARDINAL
cana-5164	295	1	12	CARDINAL
cana-5164	295	2	palomo jm	PERSON
cana-5164	295	3	guisan jm	PERSON
cana-5164	295	4	fernandez-lafuente r. improvement	PERSON
cana-5164	296	1	technol	ORG
cana-5164	297	1	2007;40:1451–63	CARDINAL
cana-5164	298	1	13	CARDINAL
cana-5164	298	2	jeong sy	PERSON
cana-5164	298	3	yoo hs	PERSON
cana-5164	300	1	2010;6:4725–33	CARDINAL
cana-5164	301	1	14	CARDINAL
cana-5164	302	1	polym-plast technol eng	ORG
cana-5164	304	1	15	CARDINAL
cana-5164	304	2	kim k-h	PERSON
cana-5164	304	3	lee j-c	PERSON
cana-5164	304	4	lee j.	PERSON
cana-5164	305	1	polym bull	PERSON
cana-5164	307	1	16	CARDINAL
cana-5164	307	2	nataly m	PERSON
cana-5164	307	3	siqueira	GPE
cana-5164	307	4	ketlin	GPE
cana-5164	307	5	garcia	PERSON
cana-5164	309	1	2015;72:998	CARDINAL
cana-5164	309	2	1004	CARDINAL
cana-5164	310	1	10.1016	CARDINAL
cana-5164	311	1	17	CARDINAL
cana-5164	311	2	wu ch	PERSON
cana-5164	311	3	guo dd	PERSON
cana-5164	314	1	2007;2	CARDINAL
cana-5164	315	1	18	CARDINAL
cana-5164	316	1	ma g	PERSON
cana-5164	316	2	yang l	PERSON
cana-5164	316	3	cheng p	PERSON
cana-5164	316	4	nie j. paclitaxel	PERSON
cana-5164	318	1	2011;86:505–12	CARDINAL
cana-5164	319	1	19	CARDINAL
cana-5164	319	2	whitehead ka	PERSON
cana-5164	319	3	mitragotri s. materials	PERSON
cana-5164	320	1	nat rev mater	PERSON
cana-5164	321	1	2020;5:127–48	CARDINAL
cana-5164	322	1	20	CARDINAL
cana-5164	322	2	gowramma b	PERSON
cana-5164	322	3	lakshmanan k	PERSON
cana-5164	322	4	reddy karri vvs	PERSON
cana-5164	322	5	radhakrishnan a.	PERSON
cana-5164	323	1	curr drug res rev	ORG
cana-5164	324	1	2020;12:16–25	CARDINAL
cana-5164	325	1	21	CARDINAL
cana-5164	325	2	liang yz	PERSON
cana-5164	325	3	ding rh	PERSON
cana-5164	325	4	wang hh	PERSON
cana-5164	325	5	liu lz	PERSON
cana-5164	325	6	tao yp	PERSON
cana-5164	327	1	2022;29:305–15	CARDINAL
cana-5164	328	1	22	CARDINAL
cana-5164	328	2	allahdad m	PERSON
cana-5164	328	3	samadian h	ORG
cana-5164	328	4	bahrami g	PERSON
cana-5164	330	1	2022	CARDINAL
cana-5164	331	1	10.1007	CARDINAL
cana-5164	332	1	23	CARDINAL
cana-5164	332	2	iraji p	PERSON
cana-5164	332	3	rahiman n	PERSON
cana-5164	332	4	abbaspour m. preparation	PERSON
cana-5164	333	1	iran	GPE
cana-5164	333	2	med sci	PERSON
cana-5164	333	3	2022;25:405	CARDINAL
cana-5164	333	4	13	CARDINAL
cana-5164	334	1	24	CARDINAL
cana-5164	334	2	mclennan dn	PERSON
cana-5164	334	3	charman sa	ORG
cana-5164	335	1	today	DATE
cana-5164	335	2	2005	DATE
cana-5164	335	3	2:89–96	CARDINAL
cana-5164	336	1	1074	CARDINAL
cana-5164	336	2	32	CARDINAL
cana-5164	337	1	2025	DATE
cana-5164	338	1	25	CARDINAL
cana-5164	338	2	101	CARDINAL
cana-5164	339	1	liu r-x	PERSON
cana-5164	339	2	li l-m	PERSON
cana-5164	339	3	wu f	PERSON
cana-5164	339	4	li ar	PERSON
cana-5164	339	5	liu x-w	PERSON
cana-5164	339	6	guo j-w.	PERSON
cana-5164	340	1	j chin med mater	PERSON
cana-5164	342	1	26	CARDINAL
cana-5164	342	2	kong	GPE
cana-5164	343	1	chin j	PERSON
cana-5164	344	1	2020	DATE
cana-5164	344	2	53:483–6	CARDINAL
cana-5164	345	1	27	CARDINAL
cana-5164	345	2	richter w	PERSON
cana-5164	345	3	schmidt j. subcutaneous	PERSON
cana-5164	347	1	28	CARDINAL
cana-5164	347	2	danilin s	GPE
cana-5164	347	3	ripoll	ORG
cana-5164	347	4	lindner	PERSON
cana-5164	349	1	2018;10:1587	CARDINAL
cana-5164	349	2	90	CARDINAL
cana-5164	350	1	29	CARDINAL
cana-5164	350	2	john jv	PERSON
cana-5164	350	3	mccarthy	PERSON
cana-5164	350	4	wang hj	PERSON
cana-5164	350	5	chen sx	PERSON
cana-5164	350	6	su yj	PERSON
cana-5164	350	7	davis e	PERSON
cana-5164	353	1	2020;16:1907393	CARDINAL
cana-5164	354	1	30	CARDINAL
cana-5164	354	2	khalil	GPE
cana-5164	354	3	saad m	PERSON
cana-5164	354	4	chakraborty j	PERSON
cana-5164	354	5	marei m.	PERSON
cana-5164	356	1	2020;13:2603	CARDINAL
cana-5164	357	1	31	CARDINAL
cana-5164	357	2	dzogbewu tc	PERSON
cana-5164	359	1	2022;10:36	DATE
cana-5164	360	1	32	CARDINAL
cana-5164	360	2	majed	ORG
cana-5164	360	3	steenbergen mj	PERSON
cana-5164	360	4	lietaert k	PERSON
cana-5164	362	1	2020;326:38–52	ORDINAL
cana-5164	363	1	33	CARDINAL
cana-5164	363	2	langer r. transdermal drug	PERSON
cana-5164	364	1	nat biotechnol	ORG
cana-5164	365	1	2008;26:1261–8	CARDINAL
cana-5164	366	1	34	CARDINAL
cana-5164	366	2	yu zx	PERSON
cana-5164	366	3	meng xx	PERSON
cana-5164	366	4	zhang sn	PERSON
cana-5164	366	5	chen ys	PERSON
cana-5164	366	6	zhang yx.	PERSON
cana-5164	370	1	35	CARDINAL
cana-5164	370	2	amirian	NORP
cana-5164	370	3	stadler fj	PERSON
cana-5164	370	4	du b	ORG
cana-5164	370	5	zhu y.	PERSON
cana-5164	372	1	2020;151:787–96	CARDINAL
cana-5164	373	1	36	CARDINAL
cana-5164	373	2	rimpelova s	PERSON
cana-5164	373	3	ulbrich p	ORG
cana-5164	374	1	sci eng	PERSON
cana-5164	375	1	2017;72:293–300	CARDINAL
cana-5164	376	1	37	CARDINAL
cana-5164	376	2	kim y-j	PERSON
cana-5164	377	1	adv funct mater	PERSON
cana-5164	378	1	2013;23:5753–61	CARDINAL
cana-5164	379	1	38	CARDINAL
cana-5164	379	2	geng	PERSON
cana-5164	379	3	liu c	PERSON
cana-5164	379	4	gao j	PERSON
cana-5164	379	5	zhou q.	PERSON
cana-5164	381	1	39	CARDINAL
cana-5164	381	2	zheng y	PERSON
cana-5164	381	3	wu y	PERSON
cana-5164	381	4	zhou y, wu j	PERSON
cana-5164	381	5	wang x	PERSON
cana-5164	383	1	2020;12:7905–14	CARDINAL
cana-5164	384	1	40	CARDINAL
cana-5164	384	2	zhe ng x	PERSON
cana-5164	384	3	liu x	PERSON
cana-5164	384	4	zha l. fabrication	PERSON
cana-5164	385	1	polym sci	PERSON
cana-5164	386	1	2020;138:50280	CARDINAL
cana-5164	387	1	41	CARDINAL
cana-5164	387	2	lutolf mp	PERSON
cana-5164	387	3	hubbell ja	PERSON
cana-5164	389	1	nat biotechnol	PERSON
cana-5164	391	1	1074	CARDINAL
cana-5164	391	2	32	CARDINAL
cana-5164	392	1	2025	CARDINAL
cana-5164	392	2	1425	CARDINAL
cana-5164	393	1	42	CARDINAL
cana-5164	393	2	niu yq	ORG
cana-5164	393	3	stadler fj	PERSON
cana-5164	393	4	yang x	PERSON
cana-5164	393	5	deng fm	PERSON
cana-5164	393	6	liu gc	PERSON
cana-5164	393	7	xia hm	PERSON
cana-5164	395	1	2021;19:283	CARDINAL
cana-5164	396	1	43	CARDINAL
cana-5164	396	2	chen z-d	PERSON
cana-5164	396	3	li y	PERSON
cana-5164	396	4	liu x-q.	PERSON
cana-5164	397	1	10th	ORDINAL
cana-5164	397	2	wuhan	GPE
cana-5164	397	3	china	GPE
cana-5164	397	4	2017	CARDINAL
cana-5164	398	1	44	CARDINAL
cana-5164	398	2	chen n	PERSON
cana-5164	398	3	ramakrishna s. nanobiomaterials	PERSON
cana-5164	399	1	regen	PERSON
cana-5164	400	1	2016;11:1372–4	CARDINAL
cana-5164	401	1	45	CARDINAL
cana-5164	401	2	kim ks	PERSON
cana-5164	401	3	kim cs	PERSON
cana-5164	401	4	simvastatin	ORG
cana-5164	403	1	2020;12:2667	CARDINAL
cana-5164	404	1	46	CARDINAL
cana-5164	405	1	zhao h	PERSON
cana-5164	405	2	muhammad h	PERSON
cana-5164	405	3	dong m	PERSON
cana-5164	405	4	chen m.	PERSON
cana-5164	406	1	sci rep	ORG
cana-5164	406	2	2017;7:8509	TIME
cana-5164	407	1	47	CARDINAL
cana-5164	407	2	ellis h. gray	PERSON
cana-5164	408	1	37th	ORDINAL
cana-5164	409	1	p. l. williams	PERSON
cana-5164	409	2	r. warwick	PERSON
cana-5164	409	3	m. dyson	PERSON
cana-5164	409	4	l. h. bannister	ORG
cana-5164	410	1	305	CARDINAL
cana-5164	412	1	1598	CARDINAL
cana-5164	414	1	1989	DATE
cana-5164	415	1	edinburgh	PERSON
cana-5164	415	2	churchill livingstone	PERSON
cana-5164	416	1	70.00	CARDINAL
cana-5164	419	1	48	CARDINAL
cana-5164	419	2	patil s	PERSON
cana-5164	419	3	tandon	GPE
cana-5164	419	4	tandon n.	GPE
cana-5164	419	5	fe3o4@sio2@k10 nps	ORG
cana-5164	419	6	j. phys	ORG
cana-5164	420	1	2022	CARDINAL
cana-5164	421	1	49	CARDINAL
cana-5164	421	2	patil s	PERSON
cana-5164	421	3	tandon	GPE
cana-5164	421	4	tandon n.	GPE
cana-5164	421	5	2022	CARDINAL
cana-5164	421	6	7	CARDINAL
cana-5164	421	7	28	CARDINAL
cana-5164	421	8	24190-24201	DATE
cana-5164	422	1	50	CARDINAL
cana-5164	422	2	kataria k	PERSON
cana-5164	422	3	gupta	GPE
cana-5164	425	1	2014;469:102–10	CARDINAL
cana-5164	426	1	51	CARDINAL
cana-5164	426	2	li l	PERSON
cana-5164	426	3	shan y	PERSON
cana-5164	426	4	xiong j	PERSON
cana-5164	427	1	zhang y, et al	PERSON
cana-5164	429	1	sci technol	PERSON
cana-5164	430	1	2019;52:272–81	CARDINAL
cana-5164	431	1	52	CARDINAL
cana-5164	431	2	varaprasad k	PERSON
cana-5164	431	3	jayaramudu t	GPE
cana-5164	431	4	karthikeyan c	ORG
cana-5164	431	5	r. carboxymethyl cellulose-	PERSON
cana-5164	434	1	53	CARDINAL
cana-5164	434	2	f. naturally-derived	PERSON
cana-5164	436	1	2019;566:307–28	ORG
cana-5164	437	1	54	CARDINAL
cana-5164	437	2	kern kb	PERSON
cana-5164	437	3	tamis-holland je	ORG
cana-5164	437	4	ramee s. cardiac	PERSON
cana-5164	438	1	j am coll cardiol	PERSON
cana-5164	439	1	2015;66:62–73	CARDINAL
cana-5164	440	1	55	CARDINAL
cana-5164	440	2	parikh	PERSON
cana-5164	440	3	poddar kl	ORG
cana-5164	440	4	kapadia sr	PERSON
cana-5164	442	1	cardiovasc	ORG
cana-5164	444	1	56	CARDINAL
cana-5164	444	2	leong kw	PERSON
cana-5164	444	3	yoo hs	PERSON
cana-5164	445	1	2008;29:587	CARDINAL
cana-5164	445	2	96	CARDINAL
cana-5164	445	3	1074	CARDINAL
cana-5164	445	4	32	CARDINAL
cana-5164	446	1	2025	CARDINAL
cana-5164	446	2	1426	CARDINAL
cana-5164	447	1	57	CARDINAL
cana-5164	447	2	azarpira n.	PERSON
cana-5164	447	3	pcl	ORG
cana-5164	450	1	58	CARDINAL
cana-5164	450	2	xu l	PERSON
cana-5164	450	3	zhao l	PERSON
cana-5164	450	4	wu	PERSON
cana-5164	450	5	zhou y	PERSON
cana-5164	451	1	adv mater	PERSON
cana-5164	452	1	2013;25:2368–73	CARDINAL
cana-5164	453	1	59	CARDINAL
cana-5164	453	2	patil s	PERSON
cana-5164	453	3	tandon	GPE
cana-5164	453	4	tandon n. magnetite-	FAC
cana-5164	453	5	k10	ORG
cana-5164	453	6	rsc adv.	PERSON
cana-5164	453	7	2023	CARDINAL
cana-5164	453	8	13	CARDINAL
cana-5164	453	9	17051-17061	DATE
cana-5164	454	1	60	CARDINAL
cana-5164	454	2	kaur g	PERSON
cana-5164	454	3	singh	GPE
cana-5164	454	4	tandon	GPE
cana-5164	454	5	tandon n.	GPE
cana-5164	454	6	inorganic chemistry communications	ORG
cana-5164	454	7	2023	CARDINAL
cana-5164	454	8	158	CARDINAL
cana-5164	454	9	111480	DATE
cana-5164	455	1	61	CARDINAL
cana-5164	455	2	duan h	GPE
cana-5164	455	3	gao c	PERSON
cana-5164	455	4	liu m	PERSON
cana-5164	455	5	wu x	PERSON
cana-5164	455	6	wei y	PERSON
cana-5164	456	1	rsc adv	PERSON
cana-5164	457	1	2014;4:27422–9	CARDINAL
cana-5164	458	1	62	CARDINAL
cana-5164	458	2	atala	GPE
cana-5164	462	1	63	CARDINAL
cana-5164	462	2	hou j	PERSON
cana-5164	462	3	xu x	PERSON
cana-5164	462	4	gao j	PERSON
cana-5164	462	5	li	PERSON
cana-5164	462	6	jin j	PERSON
cana-5164	462	7	pcl	ORG
cana-5164	464	1	2016;3:1500652	DATE
cana-5164	465	1	64	CARDINAL
cana-5164	465	2	hou j	PERSON
cana-5164	465	3	zhao c	PERSON
cana-5164	465	4	xin z	PERSON
cana-5164	465	5	jin j	PERSON
cana-5164	465	6	li	PERSON
cana-5164	468	1	2015;8:2022–9	CARDINAL
cana-5164	469	1	65	CARDINAL
cana-5164	469	2	gao y	PERSON
cana-5164	469	3	truong yb	PERSON
cana-5164	469	4	zhu y	PERSON
cana-5164	469	5	kyratzis il	PERSON
cana-5164	470	1	polym sci	PERSON
cana-5164	471	1	66	CARDINAL
cana-5164	471	2	khin mm	PERSON
cana-5164	471	3	chan-park	PERSON
cana-5164	471	4	supramolecular	PERSON
cana-5164	473	1	lett	PERSON
cana-5164	474	1	2018;223:69–72	DATE
cana-5164	475	1	67	CARDINAL
cana-5164	475	2	139	CARDINAL
cana-5164	476	1	li r	PERSON
cana-5164	476	2	cheng z	PERSON
cana-5164	476	3	yu x	PERSON
cana-5164	476	4	wang s	PERSON
cana-5164	476	5	han z	ORG
cana-5164	476	6	kang l.	PERSON
cana-5164	476	7	pcl	ORG
cana-5164	476	8	pvpagnp janus nanofibers	PERSON
cana-5164	477	1	lett	PERSON
cana-5164	478	1	2019;254:206–9	CARDINAL
cana-5164	479	1	68	CARDINAL
cana-5164	479	2	kang j	PERSON
cana-5164	479	3	jonas o	PERSON
cana-5164	479	4	kang	PERSON
cana-5164	482	1	69	CARDINAL
cana-5164	482	2	fl	ORG
cana-5164	482	3	deng xd	PERSON
cana-5164	482	4	zhou yq	PERSON
cana-5164	482	5	zhang td	PERSON
cana-5164	482	6	liu yl	PERSON
cana-5164	483	1	polym adv technol	PERSON
cana-5164	485	1	70	CARDINAL
cana-5164	485	2	shakib z	PERSON
cana-5164	485	3	sanati s.	PERSON
cana-5164	485	4	j. 2017;4:197–207	PERSON
cana-5164	486	1	71	CARDINAL
cana-5164	486	2	mo	GPE
cana-5164	486	3	koc f	PERSON
cana-5164	486	4	kutlu o	PERSON
cana-5164	489	1	2018;8:790–801	DATE
cana-5164	490	1	72	CARDINAL
cana-5164	491	1	electrospun composite nanofiber	ORG
cana-5164	494	1	1074	CARDINAL
cana-5164	494	2	32	CARDINAL
cana-5164	495	1	2025	CARDINAL
cana-5164	495	2	1427	CARDINAL
cana-5164	496	1	73	CARDINAL
cana-5164	496	2	qiu x	PERSON
cana-5164	496	3	zhang x	PERSON
cana-5164	496	4	gan x	PERSON
cana-5164	499	1	2010;268:19–24	CARDINAL
cana-5164	500	1	74	CARDINAL
cana-5164	500	2	silva a	PERSON
cana-5164	500	3	figueiró m	ORG
cana-5164	500	4	caramo eb	ORG
cana-5164	500	5	moreno p	ORG
cana-5164	500	6	elisabetsky e. effects	PERSON
cana-5164	502	1	2010;17:679–83	CARDINAL
cana-5164	503	1	75	CARDINAL
cana-5164	503	2	souza ma	PERSON
cana-5164	503	3	oliveira je	PERSON
cana-5164	503	4	medeiros es	PERSON
cana-5164	503	5	glenn gm	PERSON
cana-5164	503	6	mattoso l.	PERSON
cana-5164	506	1	76	CARDINAL
cana-5164	506	2	tandon n	GPE
cana-5164	507	1	asian journal of chemistry	ORG
cana-5164	507	2	2017 30(1	DATE
cana-5164	507	3	5–14	CARDINAL
cana-5164	508	1	77	CARDINAL
cana-5164	508	2	tandon	GPE
cana-5164	508	3	paul k.	PERSON
cana-5164	508	4	asian	NORP
cana-5164	508	5	j. org	ORG
cana-5164	509	1	2020	DATE
cana-5164	509	2	9	CARDINAL
cana-5164	509	3	1432	DATE
cana-5164	510	1	78	CARDINAL
cana-5164	510	2	kant d	PERSON
cana-5164	510	3	tandon	GPE
cana-5164	510	4	paul k.	PERSON
cana-5164	510	5	rsc adv	PERSON
cana-5164	511	1	2021;11	CARDINAL
cana-5164	511	2	25228-25257	DATE
cana-5164	512	1	79	CARDINAL
cana-5164	512	2	tandon n	GPE
cana-5164	512	3	tandon r.	NORP
cana-5164	513	1	2022	CARDINAL